The serum level of endothelin-1 has been studied as a potential risk marker for adverse cardiovascular events (atherosclerosis, CAD, arterial hypertension, myocardial infarction, heart failure, increased left atrial diameter and left ventricular mass) [29,30]. This evidence concerns the gene EDN1 and atherosclerosis.